Efficacy of Methimazole Dosing Algorithm

Status Recruiting

Clinical Trial Summary

To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.

Clinical Trial Description

To conduct a prospective observational study in 60 patients with newly diagnosed Graves' disease who are either methimazole naive or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm and assess for efficacy and safety of MMI dosing administered. Study group size is based on 90% power and projected efficacy of 70% patients reaching target. ;

Study Design

Related Conditions & MeSH terms

Graves Disease

Clinical Trial Details

NCT number	NCT05964452
Study type	Observational
Source	Cook County Health
Contact	Dan Mihailescu, MD
Phone	312-864-0531
Email	dan.mihailescu@cookcountyhhs.org
Status	Recruiting
Phase
Start date	February 14, 2022
Completion date	February 14, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05774535` - Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
Completed	`NCT02973802` - ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy	Phase 1
Completed	`NCT02491567` - DNA Methylation and Autoimmune Thyroid Diseases
Terminated	`NCT01320813` - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy	N/A
Completed	`NCT00432146` - Effect of Lugol's Solution in the Patients With Graves' Disease	N/A
Recruiting	`NCT06081439` - Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
Recruiting	`NCT05635266` - A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Active, not recruiting	`NCT04135573` - The Relationship Between NK Cell and Graves' Disease
Recruiting	`NCT06134219` - Course for Brain Fatigue After Graves' Disease Controlled Study	N/A
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Recruiting	`NCT05678374` - Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Completed	`NCT03009357` - Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Recruiting	`NCT05510609` - Three-dimensional Ultrasonography Thyroid Volume Measurement.	N/A
Recruiting	`NCT05907668` - A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease	Phase 2
Recruiting	`NCT06275373` - The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Recruiting	`NCT03303053` - Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism	Phase 3
Recruiting	`NCT05461820` - Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease	Phase 4
Recruiting	`NCT06309316` - The Impact of Person Centred Care (PCC) in Grave's Disease	N/A
Completed	`NCT00782366` - Predictive Genetic Risk Assessment Trial	N/A